Table 1.
Mice n | γδ-IEL per mouse, × 106 | Subset of γδ-IEL, %
|
||||
---|---|---|---|---|---|---|
Thy-1+ | Vγ1+ | Vγ4+ | Vγ7+ | Vδ4+ | ||
wt 8 | 3.05 ± 0.68 | 27.5 ± 10.9 | 34.7 ± 5.7 | 10.3 ± 4.1 | 52.8 ± 11.8 | 14.0 ± 3.6 |
β−/− 9 | 4.24 ± 1.06 | 23.1 ± 1.6 | 55.3 ± 4.5 | 8.2 ± 1.4 | 38.9 ± 7.0 | 11.3 ± 1.4 |
α−/− 8 | 4.90 ± 1.91 | 43.4 ± 12.0 | 45.5 ± 13.6 | 9.1 ± 7.6 | 43.5 ± 11.3 | 21.9 ± 5.8 |
IEL isolated from wt, β−/− and α−/− mice were incubated first with anti-Thy-1.2 mAb (biotinylated) and then with streptavidin–phycoerythrin and anti-TCR-γδ mAb (FITC-conjugated). These IEL were also incubated first with anti-Vγ1, anti-Vγ4, anti-Vγ7, or anti-Vδ4 mAb. After washing, the IEL were incubated with biotinylated goat anti-hamster IgG and subsequently counterstained with streptavidin-phycoerythrin and anti-TCR-γδ mAb (FITC-conjugated). The proportion of Thy-1+ cells in α−/− γδ-IEL was significantly higher than those in wt (P < 0.05) and β−/− (P < 0.01) γδ-IEL. The proportion of Vδ4+ cells in α−/− γδ-IEL was significantly higher than those in wt (P < 0.01) and β−/− (P < 0.01) γδ-IEL.